Cargando…
Corrigendum: Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma
Autores principales: | Liu, Shengye, Liu, Jiamei, Yu, Xuechen, Shen, Tao, Fu, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080027/ https://www.ncbi.nlm.nih.gov/pubmed/33937083 http://dx.doi.org/10.3389/fonc.2021.671129 |
Ejemplares similares
-
Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma
por: Liu, Shengye, et al.
Publicado: (2020) -
Emerging Roles and Potential Biological Value of CircRNA in Osteosarcoma
por: Liu, Jiamei, et al.
Publicado: (2020) -
EPB41L4A-AS1 and UNC5B-AS1 have diagnostic and prognostic significance in osteosarcoma
por: Yan, Ying, et al.
Publicado: (2023) -
Clinical prognostic implications of EPB41L4A expression in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2020) -
Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma
por: Yang, Liyu, et al.
Publicado: (2023)